No shared counterparties.
| Stage | AGX | % of rev | LMB | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $384M | 100.00% | $230M | 100.00% | AGX ×1.67 |
| Gross profit | $74M | 19.33% | $54M | 23.36% | LMB +4.0pp |
| Operating income | $57M | 14.79% | $15M | 6.54% | AGX +8.3pp |
| Pre-tax income | $67M | 17.42% | $14M | 5.98% | AGX +11.4pp |
| Net income | $53M | 13.88% | $9M | 4.10% | AGX +9.8pp |
| Stage | AGX | LMB | Gap · A − B |
|---|---|---|---|
| Revenue | $384M100.00% | $230M100.00% | AGX ×1.67 |
| Gross profit | 19.33%$74M | 23.36%$54M | LMB +4.0pp |
| Operating income | 14.79%$57M | 6.54%$15M | AGX +8.3pp |
| Pre-tax income | 17.42%$67M | 5.98%$14M | AGX +11.4pp |
| Net income | 13.88%$53M | 4.10%$9M | AGX +9.8pp |